Evidence map›Paper›PMID 38260284›Full record

ArticleResearch square2024

Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer's disease.

Valborg Gudmundsdottir, Elisabet Frick, Valur Emilsson, Thorarinn Jonmundsson, Anna Steindorsdottir, Erik C B Johnson, Raquel Puerta, Eric Dammer, Anantharaman Shantaraman, Amanda Cano and 17 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 4 institutions in 5 countries.

Valborg GudmundsdottirUniversity of Iceland.ORCID 0000-0002-7459-1603
Elisabet FrickIcelandic Heart Association.
Valur EmilssonIcelandic Heart Association.ORCID 0000-0001-9982-0524
Thorarinn JonmundssonIcelandic Heart Association.ORCID 0000-0001-9158-0087
Anna SteindorsdottirUniversity of Iceland.
Erik C B JohnsonEmory University School of Medicine.ORCID 0000-0002-0604-2944
Raquel PuertaAce Alzheimer Center Barcelona.
Eric DammerEmory University.ORCID 0000-0003-2947-7606
Anantharaman ShantaramanGoizueta Alzheimer's Disease Research Center.
Amanda CanoAce Alzheimer Center Barcelona.
Merce BoadaResearch Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades-UIC, Barcelona.ORCID 0000-0003-2617-3009
Sergi ValeroAce Alzheimer Center Barcelona.
Pablo Garcia-GonzalezAce Alzheimer Center Barcelona.
Elias GudmundssonIcelandic Heart Association.ORCID 0000-0002-7661-4872
Alexander GudjonssonIcelandic Heart Association.
Rebecca PittsNovartis Institutes for Biomedical Research.ORCID 0000-0003-4733-414X
Xiazi QiuNovartis.ORCID 0000-0002-8397-2168
Nancy FinkelNovartis Institutes for Biomedical Research.
Joseph Loureiro
Anthony OrthNovartis.ORCID 0009-0005-9865-0494
Nicholas SeyfriedEmory University School of Medicine.ORCID 0000-0002-4507-624X
Allan LeveyEmory.ORCID 0000-0002-3153-502X
Agustín RuizFundació ACE.ORCID 0000-0003-2633-2495
Thor AspelundUniversity of Iceland.ORCID 0000-0002-7998-5433
Lori JenningsNovartis.ORCID 0000-0001-5130-8417
Lenore LaunerNational Institute on Aging, National Institutes of Health.ORCID 0000-0002-3238-7612
Vilmundur GudnasonIcelandic Heart Association.ORCID 0000-0001-5696-0084
Novartis (Switzerland) · CHIcelandic Heart Association · ISNovartis (China) · CNUniversity of Iceland · IS

Funding

The Goizueta Alzheimer's Disease Research CenterP30AG066511 · NIA · EMORY UNIVERSITY · PI DAVID WEINSHENKER · 2020 to 2026
$29.0M
Supplement to AMP-AD Brain Proteomic Network Enhancement, Validation and Translation into CSF BiomarkersU01AG061357 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I, SEYFRIED, NICHOLAS THOMAS · 2018 to 2022
$9.1M
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik studyR01AG065596 · NIA · ICELANDIC HEART ASSOCIATION · PI Valborg Gudmundsdottir · 2021 to 2026
$2.6M
Brain Proteomic Network Analysis to Elucidate Mechanisms and Biomarkers for Alzheimer's DiseaseK08AG068604 · NIA · EMORY UNIVERSITY · PI JOHNSON, ERIK C.B. · 2020 to 2024
$762k
AGES STUDY-THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENNIUM-26012100N01AG012100 · NIA · ICELANDIC HEART ASSOCIATION · 2002 to 2004
–
NIA NIH HHS K08 AG068604NIA NIH HHS N01 AG012100NIA NIH HHS P30 AG066511NIA NIH HHS R01 AG065596NIA NIH HHS U01 AG061357NIDA NIH HHS HHSN271201200022C
6 · The paper itself

Abstract

The current demand for early intervention, prevention, and treatment of late onset Alzheimer's disease (LOAD) warrants deeper understanding of the underlying molecular processes which could contribute to biomarker and drug target discovery. Utilizing high-throughput proteomic measurements in serum from a prospective population-based cohort of older adults (n = 5,294), we identified 303 unique proteins associated with incident LOAD (median follow-up 12.8 years). Over 40% of these proteins were associated with LOAD

Indexed as

Alzheimer’s diseaseAPOEBrainCross-sectional studyCSFLongitudinal studyMendelian randomizationNetworkProteomics

Identifiers

PMID38260284
PMCPMC10802738
OpenAlexW4390731892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.